Long-term BHV-7000 safety study for major depression
About this title
Read the official source — NCT06423781Researchers studied BHV-7000, tracking side effects to assess long-term safety and tolerability in people with depression.
Understand this study
What did researchers investigate?
Researchers studied BHV-7000, tracking side effects to assess long-term safety and tolerability in people with depression.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.
- Listed locations
- Chandler and 65 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 233
- Sponsor
- Biohaven Therapeutics Ltd.
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT06423781
- Official title
Show the full official title
A Phase 2, Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of BHV-7000 in Treatment of Major Depressive Disorder (MDD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Chandler · Phoenix · Little Rock
58 more locations
- Rogers
- Anaheim
- Bellflower
- Chino
- Encino
- Garden Grove
- Los Angeles
- Oceanside
- Orange
- Redlands
- Riverside
- San Jose
- Stanford
- Torrance
- Upland
- Walnut Creek
- Colorado Springs
- Farmington
- Norwich
- Jacksonville
- Miami Lakes
- Orlando
- Tampa
- West Palm Beach
- Decatur
- Savannah
- Chicago
- Elgin
- Overland Park
- New Orleans
- Baltimore
- Gaithersburg
- Boston
- Watertown
- Flowood
- St Louis
- Las Vegas
- Cherry Hill
- Toms River
- Brooklyn
- Cedarhurst
- Mount Kisco
- New York
- Staten Island
- Dayton
- Portland
- Allentown
- Media
- Moosic
- North Charleston
- Austin
- Dallas
- DeSoto
- Houston
- Plano
- Wichita Falls
- Clinton
- Bellevue
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers studied BHV-7000, tracking side effects to assess long-term safety and tolerability in people with depression.
Who is behind this study?
The study sponsor is Biohaven Therapeutics Ltd.
Did this study involve medication?
Yes. The study involved medication, including BHV-7000.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.
